馬ヘルスケアの世界市場レポート 2025年

馬ヘルスケア市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4％で19億1,000万米ドルに成長します。予測期間の成長は、遺伝子検査と個別化医療、馬のウェルネス・プログラム、馬術イベントの世界化、人獣共通感染症への備え、アンチ・ドーピング規制への対応などに起因すると考えられます。予測期間の主な動向には、遠隔医療と遠隔モニタリングソリューション、馬用ウェアラブル技術、馬のリハビリテーションと理学療法、馬の歯科治療と歯科サービス、ハーブと代替療法などが含まれます。

動物ヘルスケアに対する意識の高まりは、予測期間を通じて馬ヘルスケア市場の成長を促進すると予想されます。生態系において動物が果たす重要な役割に対する意識が高まり、動物の健康は自分自身の安全と幸福のためだけでなく、人間の健康にとっても不可欠であることを認識するようになっています。動物が罹患するヘルスケアは容易に人に感染する可能性があるため、政府や民間団体はさまざまな国々で動物ヘルスケア・インフラの開発に投資するよう促しています。例えば2023年2月、英国のデータ分析・調査会社Euromonitor International Ltd.の調査によると、ペットの治療を毎日またはほぼ毎日行う頻度は2021年の26%から2023年には29%に増加しました。消費者は嗜好品よりも健康を優先し、栄養価が高く機能的なおやつを求めています。その結果、動物ヘルスケアに対する意識の高まりが、予測期間中の市場拡大に寄与すると思われます。

馬ヘルスケア市場は、人獣共通感染症の増加により成長が加速すると予想されます。これらの感染症は、ウイルス、細菌、寄生虫、真菌などの病原体によって引き起こされ、動物と人間の間で感染する可能性があります。馬ヘルスケア市場の拡大は、人獣共通感染症の発生が増加し、馬の所有者が動物の予防対策とヘルスケアを優先するようになったことに起因しています。この動向に拍車をかけているのが、人獣共通感染症に関連するリスクに対する意識の高まりと、獣医学的製品やサービスの導入拡大です。例えば、スウェーデンに本部を置く政府機関、欧州疾病予防管理センターの報告書は2022年12月、カンピロバクテリウム症が依然として最も流行している人獣共通感染症であり、報告された症例数は2022年に127,840件に上ることを明らかにしました。カンピロバクター症患者の主な報告源は鶏肉とトルコ肉であることが確認されました。サルモネラ菌は2番目に多い人獣共通感染症で、60,050人が罹患しました。カンピロバクター症、サルモネラ症に続いて、エルシニー症（6,789例）、シガトキシン産生大腸菌感染症（6,084例）、リステリア症（2,183例）が最も多く報告された人獣共通感染症でした。その結果、馬ヘルスケア市場の成長は、人獣共通感染症の発生件数の増加が牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界馬ヘルスケア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の馬ヘルスケア市場：成長率分析
• 世界の馬ヘルスケア市場の実績：規模と成長, 2019-2024
• 世界の馬ヘルスケア市場の予測：規模と成長, 2024-2029, 2034F
• 世界馬ヘルスケア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の馬ヘルスケア市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エポエチンアルファ
• エポエチンベータ
• ダルベポエチンアルファ
• その他の製品
• 世界の馬ヘルスケア市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学者
• バイオシミラー
• 世界の馬ヘルスケア市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 血液学
• 腎臓疾患
• 神経学
• その他の用途
• 世界の馬ヘルスケア市場エポエチンアルファのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エポエチンアルファ
• エポエチンアルファバイオシミラー
• 世界の馬ヘルスケア市場エポエチンベータのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エポエチンベータ
• エポエチンベータバイオシミラー
• 世界の馬ヘルスケア市場、ダルベポエチンアルファのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ダルベポエチンアルファ
• ダルベポエチンアルファバイオシミラー
• 世界の馬ヘルスケア市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペギネサチド
• その他の新しいEPO製品

第7章 地域別・国別分析

• 世界の馬ヘルスケア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の馬ヘルスケア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 馬ヘルスケア市場：競合情勢
• 馬ヘルスケア市場：企業プロファイル
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• 3SBio Inc.
• Celltrion Inc.
• Intas Pharmaceuticals Ltd.
• Boehringer Ingelheim GmbH
• Dr. Reddy's Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Reliance Life Sciences Pvt. Ltd.
• Biocon Limited
• Chugai Pharmaceutical Co.
• Kyowa Kirin Co. Ltd.
• Apotex Inc.
• CJ Healthcare Corp.
• STADA Arzneimittel AG
• Hospira Inc.
• Sandoz International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 馬ヘルスケア市場2029：新たな機会を提供する国
• 馬ヘルスケア市場2029：新たな機会を提供するセグメント
• 馬ヘルスケア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Equine healthcare encompasses services and products aimed at treating horses to improve their quality of life, enhance animal food quality, and extend their lifespan. This includes veterinary services for horses used in racing, competitive riding, and leisure, covering routine care such as vaccinations, parasite control, dental care, grooming, hoof care, and protection from natural elements.

Equine healthcare primarily comprises drugs, vaccines, and medical feed additives as its main product types. Drugs, which are pharmacologically active substances, are administered to horses in the event of various diseases such as equine influenza, equine herpes virus, equine encephalomyelitis, West Nile virus, equine rabies, Potomac horse fever, and tetanus. These products are distributed through veterinary hospitals and clinics, retail pharmacies, and online pharmacies.

The equine healthcare market research report is one of a series of new reports from The Business Research Company that provides equine healthcare market statistics, including equine healthcare industry global market size, regional shares, competitors with an equine healthcare market share, detailed equine healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the equine healthcare industry. This equine healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The equine healthcare market size has grown strongly in recent years. It will grow from $1.41 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to equine aging population, preventive healthcare practices, equestrian sports and activities, rising awareness among owners, disease outbreaks and control.

The equine healthcare market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to genetic testing and personalized medicine, equine wellness programs, globalization of equine events, zoonotic disease preparedness, compliance with anti-doping regulations. Major trends in the forecast period include telemedicine and remote monitoring solutions, wearable technologies for horses, equine rehabilitation and physical therapy, equine dental care and dentistry services, herbal and alternative therapies.

The rising awareness of animal healthcare is expected to drive the growth of the equine healthcare market throughout the forecast period. Individuals are becoming increasingly conscious of the vital role animals play in the ecosystem, recognizing that animal health is essential not only for their own safety and well-being but also for that of humans. Diseases affecting animals can easily be transmitted to people, prompting governments and private organizations to invest in developing animal healthcare infrastructure across various countries. For instance, in February 2023, a survey by Euromonitor International Ltd., a UK-based data analytics and research firm, revealed that the frequency of daily or nearly daily pet treatment increased from 26% in 2021 to 29% in 2023. Consumers are prioritizing health over indulgence and are seeking nourishing and functional treats. Consequently, the growing awareness of animal healthcare will contribute to the market's expansion during the forecast period.

The equine healthcare market is expected to see an upswing in growth due to the increasing occurrences of zoonotic diseases. These infectious diseases, caused by pathogens such as viruses, bacteria, parasites, or fungi, have the potential to be transmitted between animals and humans. The expansion of the equine healthcare market is attributed to the heightened incidences of zoonotic diseases, prompting horse owners to prioritize preventive measures and healthcare for their animals. This trend is fueled by a heightened awareness of the risks associated with zoonotic transmission and the growing adoption of veterinary products and services. For instance, a report by the European Centre for Disease Prevention and Control, a government agency based in Sweden, revealed in December 2022 that Campylobacteriosis remains the most prevalent zoonosis, with reported cases rising to 127,840 in 2022. Chicken and turkey meat were identified as the primary sources of reported campylobacteriosis cases. Salmonella, the second-most common zoonosis, affected 60,050 individuals. Subsequent to Campylobacteriosis and Salmonellosis, Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) were the most frequently reported zoonotic diseases. Consequently, the growth of the equine healthcare market is driven by the increasing incidences of zoonotic diseases.

Major companies in the equine healthcare market are concentrating on the development of preventative healthcare programs that offer predictable costs and stress the importance of early treatment. These programs are designed to assist horse owners in managing expenses and encourage the early diagnosis of health issues, thereby enhancing overall equine welfare. For example, in September 2024, Hook Norton Veterinary Group (HNVG Ltd) introduced the Equiplan Gold Health Care Scheme, which aims to improve veterinary services for equines. This scheme focuses on preventative healthcare, specifically targeting horse owners to ensure predictable veterinary costs and promote early intervention for minor issues before they escalate into emergencies. By fostering proactive care, the initiative aims to enhance the overall welfare of horses while reducing financial burdens for their owners.

Prominent companies in the equine healthcare market are actively engaged in the development of innovative products, including protein-based vaccines, to expand their customer bases, boost sales, and increase revenue. Protein-based vaccines typically involve utilizing specific proteins or antigens from the target pathogen to stimulate an immune response, avoiding the use of the live or killed form of the pathogen itself. An exemplary instance of this trend is seen in the actions of Dechra Pharmaceuticals PLC, a pharmaceutical company based in the UK. In August 2022, the company introduced the Strangvac vaccine tailored for horses and ponies. Strangvac is the only intramuscular vaccine designed to provide protection against strangles, a disease caused by the bacterium Streptococcus equi. Noteworthy for its composition, Strangvac incorporates recombinant proteins CCE, Eq85, and IdeE derived from Streptococcus equi. It features a Differentiating Infected from Vaccinated Animals (DIVA) capability. A distinct aspect of this vaccine is its formulation without live bacteria or bacterial DNA, ensuring that it does not yield positive results in culture or PCR tests. This unique feature enhances the vaccine's efficacy and safety in preventing strangles in horses.

In January 2024, Altano Group, a veterinary healthcare company based in Canada, acquired McKee Pownall Equine Services for an undisclosed sum. This acquisition underscores Altano's dedication to improving global equine healthcare by expanding its service offerings and promoting knowledge exchange within the equine veterinary sector. McKee Pownall Equine Services is a Canada-based firm that focuses on performance horse care, general wellness, and emergency veterinary services.

Major companies operating in the equine healthcare market include Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Hilltop BioSciences Inc., Dechra Pharmaceuticals plc, CVS Group PLC, Vetoquinol, Purina Animal Nutrition LLC, Applied Biologics, SOUND, Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Addison Biological Laboratory Inc., Animart LLC, Prisma Imaging, Bimini LLC, Equine Therapy Solutions

North America was the largest region in the equine healthcare market in 2024. The regions covered in the equine healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the equine healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The equine healthcare market includes revenues earned by entities by taking care of a horse for vaccinations, parasite control, and dental care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Equine Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on equine healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for equine healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The equine healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Drugs; Vaccines; Medical Feed Additives
• 2) By Disease: Equine Influenza; Equine Herpes virus; Equine Encephalomyelitis; West Nile Virus; Equine Rabies; Potomac Horse Fever; Tetanus
• 3) By Distribution: Veterinary Hospitals And Clinics; Retail Pharmacy; Online Pharmacies
• Subsegments:
• 1) By Drugs: Anti-Inflammatories; Antibiotics; Pain Management Medications; Anesthetics; Hormonal Therapies
• 2) By Vaccines: Core Vaccines; Risk-Based Vaccines; Combination Vaccines
• 3) By Medical Feed Additives: Nutritional Supplements; Probiotics And Prebiotics; Performance Enhancers; Medicated Feeds
• Companies Mentioned: Merck & Co. Inc.; Boehringer Ingelheim; Zoetis Inc.; Patterson Companies Inc.; Elanco
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Equine Healthcare Market Characteristics

3. Equine Healthcare Market Trends And Strategies

4. Equine Healthcare Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Equine Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Equine Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Equine Healthcare Market Growth Rate Analysis
• 5.4. Global Equine Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Equine Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Equine Healthcare Total Addressable Market (TAM)

6. Equine Healthcare Market Segmentation

• 6.1. Global Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Other Products
• 6.2. Global Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologist
• Biosimilar
• 6.3. Global Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Hematology
• Renal Diseases
• Neurology
• Other Applications
• 6.4. Global Equine Healthcare Market, Sub-Segmentation Of Epoetin-Alfa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-Alfa
• Epoetin-Alfa Biosimilars
• 6.5. Global Equine Healthcare Market, Sub-Segmentation Of Epoetin-Beta, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-Beta
• Epoetin-Beta Biosimilars
• 6.6. Global Equine Healthcare Market, Sub-Segmentation Of Darbepoetin-Alfa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Darbepoetin-Alfa
• Darbepoetin-Alfa Biosimilars
• 6.7. Global Equine Healthcare Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peginesatide
• Other Novel EPO Products

7. Equine Healthcare Market Regional And Country Analysis

• 7.1. Global Equine Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Equine Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Equine Healthcare Market

• 8.1. Asia-Pacific Equine Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Equine Healthcare Market

• 9.1. China Equine Healthcare Market Overview
• 9.2. China Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Equine Healthcare Market

• 10.1. India Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Equine Healthcare Market

• 11.1. Japan Equine Healthcare Market Overview
• 11.2. Japan Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Equine Healthcare Market

• 12.1. Australia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Equine Healthcare Market

• 13.1. Indonesia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Equine Healthcare Market

• 14.1. South Korea Equine Healthcare Market Overview
• 14.2. South Korea Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Equine Healthcare Market

• 15.1. Western Europe Equine Healthcare Market Overview
• 15.2. Western Europe Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Equine Healthcare Market

• 16.1. UK Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Equine Healthcare Market

• 17.1. Germany Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Equine Healthcare Market

• 18.1. France Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Equine Healthcare Market

• 19.1. Italy Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Equine Healthcare Market

• 20.1. Spain Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Equine Healthcare Market

• 21.1. Eastern Europe Equine Healthcare Market Overview
• 21.2. Eastern Europe Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Equine Healthcare Market

• 22.1. Russia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Equine Healthcare Market

• 23.1. North America Equine Healthcare Market Overview
• 23.2. North America Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Equine Healthcare Market

• 24.1. USA Equine Healthcare Market Overview
• 24.2. USA Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Equine Healthcare Market

• 25.1. Canada Equine Healthcare Market Overview
• 25.2. Canada Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Equine Healthcare Market

• 26.1. South America Equine Healthcare Market Overview
• 26.2. South America Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Equine Healthcare Market

• 27.1. Brazil Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Equine Healthcare Market

• 28.1. Middle East Equine Healthcare Market Overview
• 28.2. Middle East Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Equine Healthcare Market

• 29.1. Africa Equine Healthcare Market Overview
• 29.2. Africa Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Equine Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Equine Healthcare Market Competitive Landscape
• 30.2. Equine Healthcare Market Company Profiles
  • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Equine Healthcare Market Other Major And Innovative Companies

• 31.1. 3SBio Inc.
• 31.2. Celltrion Inc.
• 31.3. Intas Pharmaceuticals Ltd.
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Sun Pharmaceutical Industries Ltd.
• 31.7. Reliance Life Sciences Pvt. Ltd.
• 31.8. Biocon Limited
• 31.9. Chugai Pharmaceutical Co.
• 31.10. Kyowa Kirin Co. Ltd.
• 31.11. Apotex Inc.
• 31.12. CJ Healthcare Corp.
• 31.13. STADA Arzneimittel AG
• 31.14. Hospira Inc.
• 31.15. Sandoz International GmbH

32. Global Equine Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Equine Healthcare Market

34. Recent Developments In The Equine Healthcare Market

35. Equine Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Equine Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Equine Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Equine Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer